JCO Early Release, published online ahead of print Mar 10 2008
Journal of Clinical Oncology, 10.1200/JCO.2007.14.7744
Optimizing Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer: Treating the Right Patients for the Right Length of Time
Nancy U. Lin and Eric P. Winer
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
Related Articles
- Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen
Paul E. Goss, James N. Ingle, Joseph L. Pater, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David A. Cameron, Michael J. Palmer, and Dongsheng Tu
JCO 2008 26: 1948-1955
[Abstract]
[Full Text]
- Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17
Hyman B. Muss, Dongsheng Tu, James N. Ingle, Silvana Martino, Nicholas J. Robert, Joseph L. Pater, Timothy J. Whelan, Michael J. Palmer, Martine J. Piccart, Lois E. Shepherd, Kathleen I. Pritchard, Zhi He, and Paul E. Goss
JCO 2008 26: 1956-1964
[Abstract]
[Full Text]
- Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial
Eleftherios P. Mamounas, Jong-Hyeon Jeong, D. Lawrence Wickerham, Roy E. Smith, Patricia A. Ganz, Stephanie R. Land, Andrea Eisen, Louis Fehrenbacher, William B. Farrar, James N. Atkins, Eduardo R. Pajon, Victor G. Vogel, Joan F. Kroener, Laura F. Hutchins, André Robidoux, James L. Hoehn, James N. Ingle, Charles E. Geyer, Jr, Joseph P. Costantino, and Norman Wolmark
JCO 2008 26: 1965-1971
[Abstract]
[Full Text]
- Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial
Diana Crivellari, Zhuoxin Sun, Alan S. Coates, Karen N. Price, Beat Thürlimann, Henning Mouridsen, Louis Mauriac, John F. Forbes, Robert J. Paridaens, Monica Castiglione-Gertsch, Richard D. Gelber, Marco Colleoni, István Láng, Lucia Del Mastro, Laurence Gladieff, Manuela Rabaglio, Ian E. Smith, Jacquie H. Chirgwin, and Aron Goldhirsch
JCO 2008 26: 1972-1979
[Abstract]
[Full Text]
This article has been cited by other articles:
|
|
|
|
 
Aromatase Inhibitors in Preventing Breast Cancer Recurrence After 5 Years of Tamoxifen
Journal Watch Women's Health,
May 1, 2008;
2008(501):
1 - 1.
[Full Text]
|
|
|
|
